Skip to main content
Opthea Ltd logo

Opthea Ltd — Investor Relations & Filings

Ticker · OPT ISIN · US68386J2087 LEI · 549300Q5FMFDLP46SF83 ASX Manufacturing
Filings indexed 1,390 across all filing types
Latest filing 2014-10-23 Major Shareholding Noti…
Country AU Australia
Listing ASX OPT

About Opthea Ltd

https://opthea.com/

Opthea is a clinical-stage biopharmaceutical company focused on developing novel therapies for vision-threatening retinal diseases, particularly wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The company's lead product candidate, sozinibercept, is a first-in-class biologic 'trap' inhibitor targeting Vascular Endothelial Growth Factors C and D (VEGF-C and VEGF-D). Sozinibercept is being developed for administration in combination with standard-of-care anti-VEGF-A therapies. This dual-pathway inhibition aims to deliver superior visual outcomes by more comprehensively blocking the mechanisms that contribute to disease progression, addressing the limitations of current treatments that only target VEGF-A. The therapy is being evaluated in late-stage pivotal clinical trials for wet AMD.

Recent filings

Filing Released Lang Actions
Becoming a substantial holder 2 pages 68.2KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 under the Corporations Act 2001 Section 671B, titled 'Notice of initial substantial holder.' It details the substantial shareholding of Deutsche Bank AG and its related bodies corporate in Circadian Technologies Ltd, including voting power, relevant interests, registered holders, consideration paid, and associates. This type of filing is a notification of a major shareholding crossing a threshold, which aligns with the definition of 'Major Shareholding Notification' (Code: MRQ). The document is not an annual report, financial statement, or any other report type but a regulatory notification about share ownership levels.
2014-10-23 English
Circadian Appendix 3B 13 pages 167.5KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the number and class of shares issued, issue price, purpose of the issue, and compliance with ASX rules. It references specific ASX rules (2.7, 3.10.3, etc.) and includes sections on quotation of securities and calculation of placement capacity under ASX rules 7.1 and 7.1A. The document is a formal announcement related to the issuance of new shares and application for quotation on the ASX, which aligns with the category of Capital/Financing Update (CAP). It is not a full financial report, earnings release, or regulatory filing, but a specific announcement about capital raising and share issuance.
2014-10-21 English
Placement Cleansing Notice 1 page 56.4KB
Capital/Financing Update Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) regarding the issuance of shares without disclosure under Part 6D.2 of the Act. It details the issuance of placement shares to an institutional investor and compliance with relevant provisions of the Act. The document is short (1451 characters) and is a formal announcement about a capital raising event, specifically a placement of shares. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. It is not a full financial report, audit, or regulatory filing, but a specific announcement about share issuance.
2014-10-21 English
Circadian Annual General Meeting 2014 27 pages 660.0KB
AGM Information Classification · 95% confidence The document is a notice of meeting documents for the Annual General Meeting (AGM) of Circadian Technologies Limited, dated 17 October 2014. It includes the notice of the AGM, explanatory notes, proxy form, and references to the Annual Report for 2014. The document outlines the agenda items for the AGM, including election and re-election of directors, adoption of the remuneration report, share issues, and approval of incentive plans. It is clearly a communication sent to shareholders in preparation for the AGM, containing the meeting notice and related materials, not the actual Annual Report or financial statements themselves. The document is lengthy (15,000 characters) and contains detailed meeting information, but it is not a transcript, financial report, or regulatory filing. Therefore, it fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM.
2014-10-16 English
Circadian Letter to Shareholders 2 pages 107.3KB
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about a capital raising event by Circadian Technologies Limited, specifically a non-renounceable rights issue and a placement. It includes terms of the rights issue, eligibility, offer documents, participation instructions, and important dates related to the capital raising. There is no financial statement or report content, but rather an update on financing activities and capital structure changes. The document length is 6415 characters, which is sufficient for a full announcement rather than a brief notice. The content matches the description of a Capital/Financing Update, as it provides comprehensive information about the company's fundraising activities and related terms.
2014-10-09 English
Circadian Capital Raising Prospectus 53 pages 398.9KB
Capital/Financing Update Classification · 100% confidence The document is a detailed Prospectus related to a capital raising by Circadian Technologies Limited. It includes information about a rights issue, placement offer, underwriting, timetable, and terms of the offer. The content focuses on the offer of new shares and options to shareholders and investors, the purpose and use of funds, and the effect on the company. This is a formal offering document used to solicit investment and raise capital, which fits the definition of a Capital/Financing Update (CAP). It is not an announcement of a report, nor is it a financial report, management report, or regulatory filing. The length and detail confirm it is the actual prospectus document, not just an announcement or summary.
2014-10-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.